T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
NNN REIT
NNN
$8.87B
| $42.4M | ﹤0.01% |
873,467
+773,100
| +770% | +$35.8M |
|
802
Nasdaq
NDAQ
$54.6B
| $42.4M | ﹤0.01% |
580,084
+48,467
| +9% | +$3.31M |
|
803
Kodiak Gas Services
KGS
$6.3B
| $42M | ﹤0.01% |
+1,448,133
| New | +$39.8M |
|
804
ADMA Biologics
ADMA
$2.11B
| $42M | ﹤0.01% |
2,100,134
+23,806
| +1% | +$370K |
|
805
M&T Bank
MTB
$36.6B
| $41.7M | ﹤0.01% |
234,274
-60,457
| -21% | -$10M |
|
806
GXO Logistics
GXO
$5.56B
| $41.5M | ﹤0.01% |
796,093
-76,975
| -9% | -$3.9M |
|
|
BCPC
807
Balchem Corp
BCPC
$5.65B
| $40.9M | ﹤0.01% |
232,581
+37,246
| +19% | +$6.34M |
|
|
ANSS
808
DELISTED
Ansys
ANSS
| $40.9M | ﹤0.01% |
128,437
+3,207
| +3% | +$1.02M |
|
809
AngloGold Ashanti
AU
$48.1B
| $40.6M | ﹤0.01% |
1,524,533
+213,713
| +16% | +$6.14M |
|
810
Archer Daniels Midland
ADM
$38.6B
| $40.6M | ﹤0.01% |
679,492
-23,646
| -3% | -$1.44M |
|
811
Incyte
INCY
$24.4B
| $40.2M | ﹤0.01% |
608,444
+383,332
| +170% | +$24.4M |
|
812
StoneX
SNEX
$8.05B
| $39.9M | ﹤0.01% |
1,645,387
+54,638
| +3% | +$1.29M |
|
813
Immatics
IMTX
$1.31B
| $39.9M | ﹤0.01% |
3,494,502
-145,060
| -4% | -$1.72M |
|
814
Maplebear
CART
$11.6B
| $39.6M | ﹤0.01% |
972,417
+541,644
| +126% | +$19M |
|
|
BCAX
815
Bicara Therapeutics
BCAX
$1.56B
| $39.2M | ﹤0.01% |
+1,538,934
| New | +$39.2M |
|
816
AppFolio
APPF
$7.22B
| $39.2M | ﹤0.01% |
166,318
-73,901
| -31% | -$17.3M |
|
|
BCYC
817
Bicycle Therapeutics
BCYC
$279M
| $39M | ﹤0.01% |
1,722,040
+923,539
| +116% | +$21.3M |
|
818
DTE Energy
DTE
$29B
| $38.8M | ﹤0.01% |
302,096
+3,141
| +1% | +$379K |
|
819
Everest Group
EG
$14B
| $38.7M | ﹤0.01% |
98,794
+4,673
| +5% | +$1.78M |
|
820
Diodes
DIOD
$4.48B
| $38.5M | ﹤0.01% |
601,212
+16,213
| +3% | +$1.12M |
|
|
VRNA
821
DELISTED
Verona Pharma
VRNA
| $38.4M | ﹤0.01% |
1,335,194
+385,819
| +41% | +$9.5M |
|
|
BLD
822
DELISTED
TopBuild
BLD
| $38.4M | ﹤0.01% |
94,361
-10,150
| -10% | -$4.09M |
|
823
Commercial Metals
CMC
$7.98B
| $38.3M | ﹤0.01% |
697,472
+52,888
| +8% | +$2.86M |
|
|
GRMN
824
Garmin
GRMN
$60.2B
| $38.2M | ﹤0.01% |
216,789
-15,103
| -7% | -$2.61M |
|
825
Element Solutions
ESI
$9.51B
| $37.9M | ﹤0.01% |
1,396,718
+22,223
| +2% | +$582K |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.